150 related articles for article (PubMed ID: 23146973)
1. Serum pentraxin-3 levels are associated with the severity of metabolic syndrome.
Karakas MF; Buyukkaya E; Kurt M; Motor S; Akcay AB; Karakas E; Buyukkaya Ş; Sen N
Med Princ Pract; 2013; 22(3):274-9. PubMed ID: 23146973
[TBL] [Abstract][Full Text] [Related]
2. Serum pentraxin 3 levels are associated with the complexity and severity of coronary artery disease in patients with stable angina pectoris.
Karakas MF; Buyukkaya E; Kurt M; Motor S; Akcay AB; Buyukkaya S; Karakas E; Bilen P; Sen N
J Investig Med; 2013 Feb; 61(2):278-85. PubMed ID: 23237880
[TBL] [Abstract][Full Text] [Related]
3. The serum pentraxin-3 is elevated in patients with cardiac syndrome X.
Büyükkaya E; Karakaş MF; Kurt M; Motor S; Akçay AB; Büyükkaya S; Karakaş E; Sen N
Turk Kardiyol Dern Ars; 2013 Jun; 41(4):290-5. PubMed ID: 23760115
[TBL] [Abstract][Full Text] [Related]
4. 12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetate.
Signoriello E; Iardino P; Casertano S; De Lucia D; Pucciarelli A; Puoti G; Chiosi E; Lus G
J Neuroimmunol; 2020 Nov; 348():577385. PubMed ID: 32927398
[TBL] [Abstract][Full Text] [Related]
5. Is pentraxin 3 a biomarker, a player, or both in the context of coronary atherosclerosis and metabolic factors?
Nakamura A; Miura S; Shiga Y; Norimatsu K; Miyase Y; Suematsu Y; Mitsutake R; Saku K
Heart Vessels; 2015 Nov; 30(6):752-61. PubMed ID: 25048680
[TBL] [Abstract][Full Text] [Related]
6. Role of pentraxin-3 in risk assessment of patients with metabolic syndrome.
Zlibut A; Bocsan IC; Pop RM; Vesa SC; Bheecarry K; Revnic R; Cojan-Minzat B; Lupu S; Buzoianu AD; Agoston-Coldea L
Physiol Int; 2019 Sep; 106(3):283-293. PubMed ID: 31560233
[TBL] [Abstract][Full Text] [Related]
7. Association of Plasma Pentraxin-3 Levels with Retinopathy and Systemic Factors in Diabetic Patients.
Erdenen F; Güngel H; Altunoğlu E; Şak D; Müderrisoğlu C; Koro A; Akça Güler P; Hakan Sahin ME; Simsek G; Uzun H
Metab Syndr Relat Disord; 2018 Sep; 16(7):358-365. PubMed ID: 30036122
[TBL] [Abstract][Full Text] [Related]
8. The Evaluation of Serum Pentraxin-3 and High-Sensitivity C-Reactive Protein Levels in Patients with Acute Attack of COPD.
Duran L; Unsal M; Yardan T; Kati C; Bedir A; Turkeli S; Ekiz M
Clin Lab; 2015; 61(12):1911-6. PubMed ID: 26882815
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of pentraxin-3 and other inflammatory biomarkers in migraine: Association with migraine characteristics.
Ceylan M; Bayraktutan OF; Becel S; Atis Ö; Yalcin A; Kotan D
Cephalalgia; 2016 May; 36(6):518-25. PubMed ID: 26243757
[TBL] [Abstract][Full Text] [Related]
10. Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome.
Sozer V; Kutnu M; Atahan E; Calıskaner Ozturk B; Hysi E; Cabuk C; Musellim B; Simsek G; Uzun H
Clin Respir J; 2018 Apr; 12(4):1615-1622. PubMed ID: 28960823
[TBL] [Abstract][Full Text] [Related]
11. Study on the association of serum pentraxin-3 and lysosomal-associated membrane protein-2 levels with disease activity in Chinese Takayasu's arteritis patients.
Chen Z; Hu C; Sun F; Li J; Yang Y; Tian X; Zeng X
Clin Exp Rheumatol; 2019; 37 Suppl 117(2):109-115. PubMed ID: 30943132
[TBL] [Abstract][Full Text] [Related]
12. Serum Pentraxin-3 Level in Patients Who Underwent Coronary Angiography and Relationship with Coronary Atherosclerosis.
Nerkiz P; Doganer YC; Aydogan U; Akbulut H; Parlak A; Aydogdu A; Sari O; Cayci T; Barcin C; Koc B
Med Princ Pract; 2015; 24(4):369-75. PubMed ID: 25969183
[TBL] [Abstract][Full Text] [Related]
13. Increased serum YKL-40 level is associated with the presence and severity of metabolic syndrome.
Akboğa MK; Yalçın R; Şahinarslan A; Yılmaz Demirtaş C; Paşaoğlu H; Abacı A
Anatol J Cardiol; 2016 Dec; 16(12):953-958. PubMed ID: 27443476
[TBL] [Abstract][Full Text] [Related]
14. Pentraxin-3: A new parameter in predicting the severity of diabetic foot infection?
Ozer Balin S; Sagmak Tartar A; Uğur K; Kilinç F; Telo S; Bal A; Balin M; Akbulut A
Int Wound J; 2019 Jun; 16(3):659-664. PubMed ID: 30767386
[TBL] [Abstract][Full Text] [Related]
15. Plasma pentraxin-3 levels in patients with Takayasu's arteritis during routine follow-up.
Alibaz-Oner F; Aksu K; Yentur SP; Keser G; Saruhan-Direskeneli G; Direskeneli H
Clin Exp Rheumatol; 2016; 34(3 Suppl 97):S73-6. PubMed ID: 26885720
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic value of serum pentraxin 3 levels in pulmonary contusion.
Tatli O; Kurt NB; Karaca Y; Sahin A; Aygün A; Sahin E; Katipoglu B; Eryigit U; Turkmen S
Am J Emerg Med; 2017 Mar; 35(3):425-428. PubMed ID: 27955970
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin and Pentraxin-3: Current biomarkers in inflammation in white coat hypertension.
Yavuzer H; Cengiz M; Yavuzer S; Rıza Altıparmak M; Korkmazer B; Balci H; Yaldıran AL; Uzun H
J Hum Hypertens; 2016 Jul; 30(7):424-9. PubMed ID: 26040439
[TBL] [Abstract][Full Text] [Related]
18. Changes in the inflammatory markers with advancing stages of diabetic nephropathy and the role of pentraxin-3.
Uzun S; Ozari M; Gursu M; Karadag S; Behlul A; Sari S; Koldas M; Demir S; Karaali Z; Ozturk S
Ren Fail; 2016 Sep; 38(8):1193-8. PubMed ID: 27436699
[TBL] [Abstract][Full Text] [Related]
19. Association of Plasma Pentraxin-3 Level with Lipid Levels and Cardiovascular Risk Factors in People with No History of Lipid-Lowering Medication: the Dong-gu Study.
Lee R; Ahn HR; Shin MH; Kim HN; Lee YH; Choi SW; Kweon SS
J Atheroscler Thromb; 2019 Aug; 26(8):738-745. PubMed ID: 30674758
[TBL] [Abstract][Full Text] [Related]
20. Proportional correlates of cystatin-C with pentraxin-3, visceral adiposity index and atherogenicity index of plasma but not blood indices in metabolic syndrome patients with and without prediabetes.
Al-Batsh MMW; Albsoul-Younes A; Kasabri V; Suyagh M; Alalawi S; Yasin N
Horm Mol Biol Clin Investig; 2018 Nov; 36(3):. PubMed ID: 30496135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
